Premio 2031: Bio4Dreams selects the T-SURE project

20 December 2024
  • Corporate
  • /

    T-SURE, a project developing a device for abdominal hernia repair, wins the Bio4Dreams award at Premio 2031.

    T-SURE, a project developing a device for abdominal hernia repair, has been awarded the mentorship program offered by Bio4Dreams as part of Premio 2031.

    Premio 2031 – 2024 edition

    Yesterday, December 19, 2024, at the MEET Digital Culture Center in Milan, the 2024 edition of Premio 2031 concluded with the assignment of all awards for the initiative.

    Among these was the Bio4Dreams award, which offers a mentorship and support program worth €30,000 in equity-free funding. The winner is T-SURE, with its device for abdominal hernia repair.

    The T-SURE project

    The device, available in both biocompatible and biodegradable versions, stands out for its high resistance, ease of application, and minimal impact on daily life. The project is currently in the patenting phase, with tested prototypes and preparations underway for clinical trials.

    Premio 2031: Bio4Dreams selects the T-SURE project

    20 December 2024
  • Corporate
  • /

    T-SURE, a project developing a device for abdominal hernia repair, wins the Bio4Dreams award at Premio 2031.

    T-SURE, a project developing a device for abdominal hernia repair, has been awarded the mentorship program offered by Bio4Dreams as part of Premio 2031.

    Premio 2031 – 2024 edition

    Yesterday, December 19, 2024, at the MEET Digital Culture Center in Milan, the 2024 edition of Premio 2031 concluded with the assignment of all awards for the initiative.

    Among these was the Bio4Dreams award, which offers a mentorship and support program worth €30,000 in equity-free funding. The winner is T-SURE, with its device for abdominal hernia repair.

    The T-SURE project

    The device, available in both biocompatible and biodegradable versions, stands out for its high resistance, ease of application, and minimal impact on daily life. The project is currently in the patenting phase, with tested prototypes and preparations underway for clinical trials.

    Premio 2031: Bio4Dreams selects the T-SURE project

    20 December 2024
  • Corporate
  • /

    T-SURE, a project developing a device for abdominal hernia repair, wins the Bio4Dreams award at Premio 2031.

    T-SURE, a project developing a device for abdominal hernia repair, has been awarded the mentorship program offered by Bio4Dreams as part of Premio 2031.

    Premio 2031 – 2024 edition

    Yesterday, December 19, 2024, at the MEET Digital Culture Center in Milan, the 2024 edition of Premio 2031 concluded with the assignment of all awards for the initiative.

    Among these was the Bio4Dreams award, which offers a mentorship and support program worth €30,000 in equity-free funding. The winner is T-SURE, with its device for abdominal hernia repair.

    The T-SURE project

    The device, available in both biocompatible and biodegradable versions, stands out for its high resistance, ease of application, and minimal impact on daily life. The project is currently in the patenting phase, with tested prototypes and preparations underway for clinical trials.

    Premio 2031: Bio4Dreams selects the T-SURE project

    20 December 2024
  • Corporate
  • /

    T-SURE, a project developing a device for abdominal hernia repair, wins the Bio4Dreams award at Premio 2031.

    T-SURE, a project developing a device for abdominal hernia repair, has been awarded the mentorship program offered by Bio4Dreams as part of Premio 2031.

    Premio 2031 – 2024 edition

    Yesterday, December 19, 2024, at the MEET Digital Culture Center in Milan, the 2024 edition of Premio 2031 concluded with the assignment of all awards for the initiative.

    Among these was the Bio4Dreams award, which offers a mentorship and support program worth €30,000 in equity-free funding. The winner is T-SURE, with its device for abdominal hernia repair.

    The T-SURE project

    The device, available in both biocompatible and biodegradable versions, stands out for its high resistance, ease of application, and minimal impact on daily life. The project is currently in the patenting phase, with tested prototypes and preparations underway for clinical trials.